Pharmaceutical consultants apply their comprehensive expertise in different areas to accelerate the drug development process.
side-effect profile and so on before confirming the lessons learned with only compounds deemed to have good chances of success in Phase III trials is not a new paradigm in drug development ...
BullFrog AI plans to introduce what it considers a game-changing approach that could shorten timelines, reduce costs, and increase success rates in drug development.
Pharmaceutical Technology on MSN2d
Vivace closes $35m in Series D for cancer drug developmentVivace Therapeutics has closed $35m in a Series D financing round to support the clinical development of its cancer drug ...
The investment of over $6 million will expand LGM Pharma’s Rosenberg, Texas manufacturing facility as part of its Phase I ...
Pheiron and Ribo are excited to announce that the first two strategic collaboration milestones have been successfully ...
New SEC filings from pharmaceutical companies reveal Donald Trump and Elon Musk’s cost-cutting measures could slow drug ...
Mineralys’ shares got a more than 50% boost Monday morning as new data showed its hypertension drug reduced blood pressure in ...
Patients enroll in phase 2 oncology trials seeking access to promising new treatments, but the risk-benefit assessments and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback